Angiotensin II/Angiotensin (1–7) ratio and 24-h blood pressure throughout the menstrual cycle and in women using oral contraceptives
The DOI matches its Crossref record; 58 of the 60 references it cites were found in a registry or an index.
Abstract
Background Women using oral contraceptives have higher ambulatory blood pressures (BPs) than other women. We sought to learn whether this was associated with an alteration in the balance of angiotensin II (Ang)/Ang (1-7) and whether this ratio and BP remained constant throughout the menstrual cycle. Method In total, 30 (15 ovulatory, 15 taking oral contraceptives) healthy, normotensive women aged 18-30 years were studied. The ovulatory group was assessed within days 1-5 (follicular phase) and 19-23 (luteal phase) and the oral contraceptive group within days 19-23. Peripheral, central and 24-h BP, vascular wall stiffness, and body composition were measured along with plasma estradiol, progesterone, renin, aldosterone, Ang II, and Ang (1-7) concentrations. Results In ovulatory women plasma renin activity (P Conclusion This study confirms that BP is constant throughout the normal menstrual cycle along with a constant balance between the vasoconstrictor (Ang II) and vasodilator [Ang (1-7)] arms of the renin-Ang-aldosterone system. Women taking oral contraceptives have a higher Ang II/Ang (1-7) ratio associated with their BP elevation although no causal relationship has been found.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271
Heart Disease and Stroke Statistics—2011 Update: A Report From the American Heart Association
Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Adams, R. J., Berry, J. D., Brown, T. M., Carnethon, M. R., Dai, S., de Simone, G., Ford, E. S., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182009701 · Cited by 6,149
Intention-to-treat concept: A review
Gupta, S. (2011) · Perspectives in Clinical Research · doi:10.4103/2229-3485.83221 · Cited by 1,921
Roman, M. J., Devereux, R. B., Kizer, J. R., Lee, E. T., Galloway, J. M., Ali, T., Umans, J. G., & Howard, B. V. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.089078 · Cited by 1,080
The Progression of Hypertensive Heart Disease
Drazner, M. H. (2011) · Circulation · doi:10.1161/circulationaha.108.845792 · Cited by 844
Santos, R. A. S., Ferreira, A. J., Verano-Braga, T., & Bader, M. (2013) · Journal of Endocrinology · doi:10.1530/joe-12-0341 · Cited by 523
Ferrario, C. M., & Strawn, W. B. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.01.059 · Cited by 512
SKINNER, S. L. (1967) · Circulation Research · doi:10.1161/01.res.20.4.391 · Cited by 401
Pharmacological profile of progestins
Sitruk-Ware, R. (2004) · Maturitas · doi:10.1016/j.maturitas.2004.01.001 · Cited by 374
Cited by
Stanhewicz, A. E., Wenner, M. M., & Stachenfeld, N. S. (2018) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00396.2018 · Cited by 399
“Women taking oral contraceptives 535 have also been reported to have greater circulating ang 1-7 compared to ovulatory women 536 during both the follicular and luteal phases of their ovulatory cycle, however these increases 537 were accompanied by similarly elevated ang II, and may be compensatory and/or result from a…”
BackgroundHypertension in Premenopausal and Postmenopausal Women
Brahmbhatt, Y. G., Gupta, M. M., & Hamrahian, S. M. (2019) · Current Hypertension Reports · doi:10.1007/s11906-019-0979-y · Cited by 66
Onat, B., Rosales-Solano, H., & Pawliszyn, J. B. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c01846 · Cited by 37
Ramesh, S., James, M. T., Holroyd-Leduc, J. M., Wilton, S. B., Sola, D. Y., & Ahmed, S. B. (2022) · Physiological Reports · doi:10.14814/phy2.15298 · Cited by 47
“To account for variations in sex hormone levels and renin– angiotensin aldosterone system (RAAS) activity through the menstrual cycle (Chidambaram et al., 2002), premenopausal women were studied 14 days after the 1st day of the menstrual cycle (high estradiol phase) and 11 participants were studied again on the 1st da…”
BackgroundInfluentialGunaratne, M. D. S. K., Thorsteinsdottir, B., & Garovic, V. D. (2021) · Current Hypertension Reports · doi:10.1007/s11906-021-01147-4 · Cited by 39
Metadata
- Authors
- Davis, G. C., Gibson, K. J., Casley, D., & Brown, M. A.
- Affiliations
- UNSW Sydney (AU)
- Corresponding author
- Brown, Mark A.
- ORCID
- Brown, Mark A.
- Venue
- Journal of Hypertension
- Published
- 2017-06
- Volume
- 35
- Issue
- 6
- Pages
- 1178-1186
- ISSN
- 0263-6352 (ISSN-L)
- OpenAlex
- W2590972463
- Cited by
- 13
- References
- 60
- Citations by year
- 2026: 1 · 2025: 1 · 2023: 1 · 2022: 2 · 2021: 1 · 2020: 4 · 2019: 1 · 2018: 2
- FWCI
- 1.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Hypertension (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- angiotensin II, angiotensin-(1-7), oral contraceptives, menstrual cycle, 24-hour ambulatory blood pressure, renin-angiotensin-aldosterone system, plasma renin activity, aldosterone, vascular stiffness, body composition, ovulation, luteal phase, follicular phase
- MeSH terms
- Adolescent, Adult, Angiotensin I, Angiotensin II, Blood Pressure, Contraceptives, Oral, Estradiol, Female, Humans, Menstrual Cycle, Peptide Fragments, Progesterone, Renin-Angiotensin System, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Angiotensin II/Angiotensin (1–7) ratio and 24-h blood pressure throughout the menstrual cycle and in women using oral contraceptives. https://app.cochat.ai/papers/10.1097/hjh.0000000000001310
- The paper
- Davis, G. C., Gibson, K. J., Casley, D., & Brown, M. A. (2017). Angiotensin II/Angiotensin (1–7) ratio and 24-h blood pressure throughout the menstrual cycle and in women using oral contraceptives. Journal of Hypertension. https://doi.org/10.1097/hjh.0000000000001310
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.